Guided Therapeutics (GTHP) Accumulated Expenses (2010 - 2025)
Guided Therapeutics recorded quarterly Accumulated Expenses of $9000.0 in Q4 2025, up 12.5% quarter-over-quarter from $8000.0 in Q3 2025, and down 99.11% year-over-year from $1.0 million in Q4 2024.
Guided Therapeutics' Accumulated Expenses history runs 16 years deep, the most recent figure standing at $9000.0 for Q4 2025.
- In Q4 2025, Accumulated Expenses fell 99.11% year-over-year to $9000.0; the TTM figure through Dec 2025 stood at $9000.0 (down 99.11% YoY), while the FY2025 annual figure was $9000.0, down 99.11% from the prior year.
- Accumulated Expenses came in at $9000.0 for Q4 2025 at Guided Therapeutics, up from $8000.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $4.9 million in Q1 2021 to a low of $7000.0 in Q3 2023.
- A 5-year average of $715047.2 and a median of $414500.0 in 2021 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses tumbled 99.34% in 2023 and surged 10400.0% in 2024, its largest moves.
- Guided Therapeutics' Accumulated Expenses stood at $49000.0 in 2021, then surged by 2444.9% to $1.2 million in 2022, then fell by 14.35% to $1.1 million in 2023, then decreased by 5.34% to $1.0 million in 2024, then sank by 99.11% to $9000.0 in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $9000.0, $8000.0, and $8000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 840,000.00 |
| Mar 31, 2024 | 780,000.00 |
| Dec 31, 2023 | 1.07 Mn |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 928,000.00 |
| Dec 31, 2022 | 1.25 Mn |
| Sep 30, 2022 | 1.05 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 41,000.00 |
| Dec 31, 2021 | 49,000.00 |
| Sep 30, 2021 | 32,945.00 |
| Jun 30, 2021 | 44,000.00 |
| Mar 31, 2021 | 4.90 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Sep 30, 2020 | 2.91 Mn |
| Jun 30, 2020 | 2.87 Mn |
| Mar 31, 2020 | 2.93 Mn |
| Dec 31, 2019 | 3.24 Mn |
| Sep 30, 2019 | 3.04 Mn |
| Jun 30, 2019 | 3.52 Mn |
| Mar 31, 2019 | 3.40 Mn |
| Dec 31, 2018 | 1.03 Mn |
| Sep 30, 2018 | 3.05 Mn |
| Jun 30, 2018 | 4.44 Mn |
| Mar 31, 2018 | 4.33 Mn |
| Dec 31, 2017 | 4.16 Mn |
| Sep 30, 2017 | 3.65 Mn |
| Jun 30, 2017 | 3.27 Mn |
| Mar 31, 2017 | 2.72 Mn |
| Dec 31, 2016 | 202,000.00 |
| Sep 30, 2016 | 2.31 Mn |
| Jun 30, 2016 | 2.15 Mn |
| Mar 31, 2016 | 2.07 Mn |
| Dec 31, 2015 | 56,000.00 |
| Sep 30, 2015 | 1.62 Mn |
| Jun 30, 2015 | 1.63 Mn |
| Mar 31, 2015 | 1.52 Mn |
| Dec 31, 2014 | 447,000.00 |
| Sep 30, 2014 | 914,000.00 |
| Jun 30, 2014 | 980,000.00 |
| Mar 31, 2014 | 997,000.00 |
| Dec 31, 2013 | 55,000.00 |
| Sep 30, 2013 | 575,000.00 |
| Jun 30, 2013 | 520,000.00 |
| Mar 31, 2013 | 436,000.00 |
| Dec 31, 2012 | 64,000.00 |
| Sep 30, 2012 | 608,000.00 |
| Jun 30, 2012 | 829,000.00 |
| Mar 31, 2012 | 687,000.00 |
| Dec 31, 2011 | 757,000.00 |
| Jun 30, 2011 | 773,000.00 |
| Dec 31, 2010 | 885,000.00 |